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Summary
Our series of 5 cases of histologically-proven Giant cell
myocarditis with concurrent CMR shows a pattern of
late gadolinium enhancement which tends to be wide-
spread involving all layers of the myocardium.
Background
Giant cell myocarditis (GCM) is a rare condition with
paucity of data, particularly on diagnosis, prognosis and
morphological correlation. We sought to review cases of
histologically-proven GCM to examine their presenta-
tion and investigations, and in particular, the potential
role of cardiac magnetic resonance (CMR) imaging in
the diagnosis.
Methods
Cases of histologically-proven GCM presenting to our
institution, a national transplant center, who had con-
current CMR imaging were identified. CMR findings
were evaluated from the initial and follow-up scans for
ventricular volumes, function, and late gadolinium
enhancement (LGE) on an advanced post-processing
workstation.
Results
5 patients with histologically-proven GCM had CMR
performed with 2 having repeat CMR. 4 out of the 5
patients were in cardiogenic shock at the time of biopsy
(Patients No: 1, 2, 4 and 5). Most patients were initially
too unwell for CMR. For the 5 patients, their times
from presentation at our institution to time of endo-
myocardial biopsy (and initiation of treatment soon
after) were 0, 3, 11, 0 and 8 days respectively while their
times from presentation to first CMR were 12, 31, 9, 56
and 545 days respectively. Table 1 summarizes the CMR
findings of these 5 patients and their follow-up. They
had moderate to severe reduction in left ventricular
(LV) systolic function largely due to increase in end-sys-
tolic volumes (ESV) with the end-diastolic dimensions
remaining within normal limits. All patients had LGE
affecting the myocardium of the LV with multi-focal
involvement of all layers of myocardium with no seg-
mental predisposition. 3 patients also had LGE in the
right ventricular (RV) myocardium. In the 2 patients
who had follow-up CMR, there was deterioration in LV
EF due to increasing LV ESV, as well as increasing right
ventricular (RV) volumes in the follow-up CMR. These
2 patients received steroids and their immunosuppres-
sion regime were azathioprine and ciclosprin (Patient
No: 3), and rATG (Patient No: 4). For one of the
patients, follow-up biopsy did not show active GCM,
raising the possibility of deterioration in LV EF from
adverse remodeling.
Conclusions
In the largest available CMR series of histologically-pro-
ven GCM, LGE on CMR imaging tends to be wide-
spread involving all layers of the myocardium as
opposed to the typical patterns of ‘classical’ myocarditis.
This was representative of extensive inflammation and
fibrosis which may reflect the high mortality associated
with GCM.
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CMR Findings (Median, IQR) LV EDV (ml) LV ESV (ml) LV EF (%) RV EDV
(ml) RV ESV (ml) RV EF (%)
158 (133, 175) 98 (75, 108) 39 (39, 53) 140 (123, 145) 63
(61, 75) 53 (49, 58)
LGE Patterns: Patient No: 1 Patient No: 2 Patient No: 3 Patient No: 4
Patient No: 5
Multifocal mid-wall LGE. Focal sub-endocardial LGE at LV apex and mid-
ventricle. Multifocal mid-wall LGE. Thinning of inferior wall at mid-
ventricular level. Widespread mid-wall and sub-epicardial LGE with
microaneurysms and RV involvement. Widespread mid-wall LGE and
extensive sub-epicardial inferior wall LGE. RV involvement. Near global
sub-endocardial LGE. RV involvement.
CMR Interval changes: Patient No: 3 LV EDV change LV ESV change LV EF
change RV EDV change RV ESV change RV EF change Patient No: 4 LV
EDV change LV ESV change LV EF change RV EDV change RV ESV change
RV EF change
+5 ml +15 ml -22% +13 ml +24 ml -10% +43 ml +56 ml -35% +53 ml
+19 ml +2%
Figure 1 shows (a) the widespread mid-wall LGE in the left ventricle on CMR, (b) lateral wall fibrosis on the explant specimen (H&E, x20), (c)
Giant cell myocarditis in pre-transplant diagnostic endomyocardial biopsy (H&E, x200) of Patient No: 4 who had CMR and who subsequently
underwent cardiac transplantation.
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